Aflibercept for recurrent or recalcitrant polypoidal choroidal vasculopathy in Indian eyes: Early experience

Treatment guidelines for symptomatic polypoidal choroidal vasculopathy (PCV) have been described, but the management of recurrent or recalcitrant PCV is a challenge. The newer anti-vascular endothelial growth factor: aflibercept has shown promise in the treatment of both treatment naive and recalcit...

Descripción completa

Detalles Bibliográficos
Autores principales: Bansal, Aditya, Bhende, Muna, Sharma, Tarun, Bhende, Pramod, Mukherjee, Suchetana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598194/
https://www.ncbi.nlm.nih.gov/pubmed/28820169
http://dx.doi.org/10.4103/ijo.IJO_1003_16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598194/
https://www.ncbi.nlm.nih.gov/pubmed/28820169
http://dx.doi.org/10.4103/ijo.IJO_1003_16

Ejemplares similares